Results 121 to 130 of about 30,740 (199)

A Rare Case of Adrenocorticotropic Hormone (ACTH)-Secreting Pheochromocytoma Presenting With Severe Cushing Syndrome (CS) and Dual Hormonal Secretion. [PDF]

Cureus
Aung YY, Hutton N, Hamdan S, Hadden R, Babiker T.   +4 more
europepmc   +1 more source

Abdominal Crisis in the Malignant Carcinoid Syndrome

Archives of Internal Medicine, 1966
EPISODES of acute abdominal pain during the course of the malignant carcinoid syndrome often present a major challenge to physicians caring for patients with this unique disease. The primary tumor (usually in the small intestine) rarely causes symptoms until widespread metastases occur.
C. E. Mengel
  +5 more sources

Diagnosis and Treatment of Malignant Carcinoid Syndrome

JAMA: The Journal of the American Medical Association, 1974
THE malignant carcinoid syndrome has challenged the skills of the clinician, biochemist, and pharmacologist since its original description by Biorck et al 1 22 years ago. Although attention originally centered on a symptom complex and a serotonin-producing midintestinal neoplasm that had metastasized to the liver, the carcinoid syndrome has now been ...
A. L. Ureles
openaire   +3 more sources

Cushing's and Malignant Carcinoid Syndromes From Ovarian Neoplasm

Archives of Internal Medicine, 1965
Introduction THERE is a growing appreciation of the protean nature of the so-called carcinoid tumor in terms of site of origin, histological appearance, and capacity for hormone production. 1 In addition to the now widely recognized capacity of these tumors to produce the tryptophan metabolite, serotonin (5-HT), and the serotonin precursor, 5 ...
H, BROWN, M, LANE
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Malignant Carcinoid Syndrome

Archives of Surgery, 1959
The malignant carcinoid syndrome is manifested by (1) paroxysmal flushing, (2) chronic diarrhea, (3) respiratory distress, and (4) valvular heart disease. These abnormalities result from a marked increase in the amount of circulating serotonin. The abnormal clinical findings in this syndrome result principally from the action of serotonin on the ...
Wilson, Harwell, Storer, Edward H.
openaire   +3 more sources

Malignant carcinoid syndrome

, 2004
N. Levine Prof., C. C. Levine
openaire   +2 more sources

Cutaneous Manifestations of the Malignant Carcinoid Syndrome

Annals of Internal Medicine, 1963
Charles E. Mengel
openaire   +2 more sources

Malignant carcinoid syndrome: Two case reports

Journal of Surgical Oncology, 1980
AbstractThe malignant carcinoid syndrome (MCS) is a rare complication of malignant carcinoid neoplasms, fewer than 200 cases having been reported since its description by Thorson in 1954. Its signs and symptoms vary with the site of the primary neoplasm, and MCS is now recognized as one member of the large family of endocrine tumors ‐ APUDOMAS ...
J L, Spann, D, Van Wormer, M E, Sandlin
openaire   +2 more sources

Metastatic Carcinoid Tumors and the Malignant Carcinoid Syndrome

Annals of the New York Academy of Sciences, 1994
Patients with metastatic carcinoid tumors and the malignant carcinoid syndrome have benefited immensely from diagnostic and therapeutic advances during the past decade. Magnetic resonance imaging and whole body scintigraphy with radiolabelled analogues of somatostatin have improved our ability to diagnose, detect, stage and follow response to therapy ...
openaire   +2 more sources